申请人:NPS Allelix Corporation
公开号:US20040152741A1
公开(公告)日:2004-08-05
The present invention relates to compounds of Formula 1,
1
and salts solvates and hydrates thereof. The invention further relates to pharmaceutical compositions containing said compounds and methods of treating neurological, neuropsychiatric, and gastrointestinal disorders using said compounds.
本发明涉及化合物1的盐、溶剂和水合物,以及含有该化合物的制药组合物和使用该化合物治疗神经、神经精神和胃肠疾病的方法。